CytoDyn Inc. (“CytoDyn”) (OTC QB: CYDY), a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, today announced that it will be presenting an update on the company’s technology at the BIOCOM Global Life Sciences Partnering Conference at the Lodge in Torrey Pines, La Jolla, California.
